<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph id="IFRS03_BC151" base="F4232081" principles="no"><paranum>BC151</paranum><prolog><data name="standard_number" value="IFRS 3"/><data name="paranum" value="BC151"/></prolog><body><p id="IFRS03_P2286">Relatively few respondents to the 2005 Exposure Draft commented on the proposed accounting for research and development assets. Those who did so generally disagreed with those proposals (they also generally applied US GAAP rather than IFRSs), citing either or both of the following concerns as support for their view:</p><ol id="IFRS03_L0102" base="F4232083" type="lower-alpha"><li><li_value>(a)</li_value> <p id="IFRS03_P2287" base="F4232084">In&#x2011;process research and development may not meet the definition of an asset in the FASB&#x2019;s Concepts Statement 6 because its low likelihood of success does not represent <b>probable</b> future economic benefits.</p></li><li><li_value>(b)</li_value> <p id="IFRS03_P2288" base="F4232087">The fair value of in&#x2011;process research and development may not be measurable with sufficient reliability for recognition in financial statements.</p></li></ol><p id="IFRS03_P2289" base="F4232088">The boards rejected both of those views for the reasons explained in the following paragraphs.</p></body></paragraph>